RT Journal Article
SR Electronic
T1 Virus detection and identification in minutes using single-particle imaging and deep learning
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.13.20212035
DO 10.1101/2020.10.13.20212035
A1 Shiaelis, Nicolas
A1 Tometzki, Alexander
A1 Peto, Leon
A1 McMahon, Andrew
A1 Hepp, Christof
A1 Bickerton, Erica
A1 Favard, Cyril
A1 Muriaux, Delphine
A1 Andersson, Monique
A1 Oakley, Sarah
A1 Vaughan, Alison
A1 Matthews, Philippa C.
A1 Stoesser, Nicole
A1 Crook, Derrick
A1 Kapanidis, Achillefs N.
A1 Robb, Nicole C.
YR 2020
UL http://medrxiv.org/content/early/2020/10/16/2020.10.13.20212035.abstract
AB The increasing frequency and magnitude of viral outbreaks in recent decades, epitomized by the current COVID-19 pandemic, has resulted in an urgent need for rapid and sensitive viral diagnostic methods. Here, we present a methodology for virus detection and identification that uses a convolutional neural network to distinguish between microscopy images of single intact particles of different viruses. Our assay achieves labeling, imaging and virus identification in less than five minutes and does not require any lysis, purification or amplification steps. The trained neural network was able to differentiate SARS-CoV-2 from negative clinical samples, as well as from other common respiratory pathogens such as influenza and seasonal human coronaviruses, with high accuracy. Single-particle imaging combined with deep learning offers a promising alternative to traditional viral diagnostic methods, and has the potential for significant impact.Competing Interest StatementThe work was carried out using portable commercial microscopes from Oxford Nanoimaging, a company in which A.N.K. is a co-founder and shareholder. Patent applications relating to the work have been submitted by N.C.R., A.N.K. and N.S. (PCT/GB2019/053073 and 2006155.6).Funding StatementWe are grateful to Micron Oxford, funded by Wellcome Strategic Awards (091911 and 107457; PI Ilan Davis), for their loan of their microscope and to Nadia Halidi for her help with the instrument. This research was supported by a Royal Society Dorothy Hodgkin Research Fellowship DKR00620 and Research Grant for Research Fellows RGF\R1\180054 (N.C.R.), the University of Oxford COVID-19 Research Response Fund (N.C.R and A.N.K.), a BBSRC-funded studentship (N.S.), and Wellcome Trust grant 110164/Z/15/Z (A.N.K.). All data will be available upon request.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:North West-Greater Manchester South Research Ethics Committee [REC], REC Ref:19/NW/0730All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request.